Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031086

Chief Business Officer bought 6,000 shares at $8.00 ($48,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Caffo Nathan Chief Business Officer 2021-07-29 Purchase +6,000 $8.00 $48,000 6,000 D: show line 1 in the form
Open-market purchases · 6,000 sh · avg $8.00 · $48,000
Loading xslF345X03/doc4.xml…